Role of interleukin-1β and tumour necrosis factor-α in lipopolysaccharide-induced sickness behaviour: A study with interleukin-1 type I receptor-deficient mice

European Journal of Neuroscience

Volumn 12, Issue 12, 2000, Pages 4447-4456

  Bluthé, Rose Marie ^a   Layé, Sophie ^a   Michaud, Bruno ^a   Combe, Chantal ^a   Dantzer, Robert ^a   Parnet, Patricia ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Autoradiography; Behaviour; Body weight; Cytokines; Interleukin 1 receptor type I knockout mice; Tumour necrosis factor binding protein

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE I;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; AUTORADIOGRAPHY; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; EXPLORATORY BEHAVIOR; INFECTION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE MUTANT; MOUSE STRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; SOCIAL BEHAVIOR;

ANIMALS; BRAIN; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOCIAL BEHAVIOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034352483     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.01348.x     Document Type: Article

References (52)

1. Biological activity and brain actions of recombinant rat interleukin-1 alpha and interleukin-1 beta
2. Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus
3. Interleukin-1 receptor antagonist blocks effects of IL-1α and IL-1β on social behaviour and body weight in mice
4. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat
5. Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice
6. Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats
7. Central mediation of the effects of interleukin-1 on social exploration and body weight in mice
8. Hypersensitivity of lurcher mice to the depressing effects of lipopolysaccharide and interleukin-1 on behaviour
9. Synergistic effects of inteleukin-1β, interleukin-6, and tumor necrosis factor-α: Central monoamine, corticosterone, and behavioral variations
10. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism
11. Two high-affinity interleukin-1 receptors represent separate gene products
12. The type II 'decoy' receptor: A novel regulatory pathway for interleukin-1
13. Brain type I but not type II IL-1 receptors mediate the effects of IL-1β on behavior in mice
14. Blockade of brain type II interleukin-1 receptors potentiates IL-1β-induced anorexia in mice
15. In situ histochemical localization of type I interleukin-1 receptor mRNA in the CNS, pituitary, and adrenal gland of the mouse
16. Cytokines and sickness behavior
17. Cytokine effects on behavior
18. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia
19. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice
20. Induction of tumor necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: Comparison with interleukin-1 family and interleukin-6
21. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
22. Interleukin-1β in immune cells of the abdominal vagus nerve: A link between the immune system and nervous systems?
23. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex
24. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin-1
25. Sickness behaviour as a new target for drug development
26. Role of fever in disease
27. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: A novel mechanism of regulation of IL-1 responsiveness
28. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice
29. Subdiaphragmatic vagotomy blocks induction of IL-1β mRNA in mice brain in response to peripheral LPS
30. Central administration of rat interleukin-6 induces hypothalamus-pituitary-adrenal activation and fever but not sickness behavior in rats
31. IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice
32. Rat homolog of mouse interleukin-1 receptor accessory protein: Cloning, localization and modulation studies
33. Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I
34. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein
35. A novel IL-1 receptor cloned from B cells by mammalian expression, is expressed in many cell types
36. Neuroprotective effects of TNF binding protein in focal cerebral ischemia
37. The IL-1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense
38. Molecular identification of two types of IL-1 receptors in the murine pituitary gland
39. Expression of type I and type II interleukin-1 receptors in mouse brain
40. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adenocorticotropin response to bacterial lipopolysaccharide in vivo
41. Brain mechanisms in cytokine-induced anorexia
42. Intracerebroventricular administration of a specific receptor antagonist blocks food and water intake suppression induced by interleukin-1 beta
43. Tumor necrosis factor and interleukin-1β: Suppression of food intake by direct action in the central nervous system
44. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
45. Interleukin-1 (IL-1) receptor type I mediates anorexia but not adipsia induced by centrally administered IL-1beta
46. 125I-recombinant human IL-1 receptor antagonist
47. Interleukin-1 receptors in mouse brain: Characterization and neuronal localization
48. Regulation of the hypothalamic-adrenal axis by cytokines: Actions and mechanisms of action
49. Cytokine-cytokine interactions and the brain
50. The interleukin-1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor associated kinase (IRAK) and stress-activated kinases (SAP kinases)
51. Synergistic effect of rhTNF-α and rhIL- 1α in inducing anorexia in rats